Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Inventory: 2017-2024

Historic Inventory for Organogenesis Holdings (ORGO) over the last 8 years, with Dec 2024 value amounting to $26.2 million.

  • Organogenesis Holdings' Inventory rose 46.41% to $39.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.6 million, marking a year-over-year increase of 46.41%. This contributed to the annual value of $26.2 million for FY2024, which is 7.20% down from last year.
  • Organogenesis Holdings' Inventory amounted to $26.2 million in FY2024, which was down 7.20% from $28.3 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Inventory registered a high of $28.3 million during FY2023, and its lowest value of $24.8 million during FY2022.
  • For the 3-year period, Organogenesis Holdings' Inventory averaged around $26.4 million, with its median value being $26.2 million (2024).
  • In the last 5 years, Organogenesis Holdings' Inventory rose by 21.30% in 2020 and then dropped by 9.99% in 2021.
  • Over the past 5 years, Organogenesis Holdings' Inventory (Yearly) stood at $27.8 million in 2020, then fell by 9.99% to $25.0 million in 2021, then fell by 0.96% to $24.8 million in 2022, then climbed by 14.00% to $28.3 million in 2023, then declined by 7.20% to $26.2 million in 2024.